Parasitic Infection and the Polarized Th2 Immune Response Can Alter a Vaccine-Induced Immune Response
- 1 June 2003
- journal article
- review article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 22 (6) , 421-430
- https://doi.org/10.1089/104454903767650685
Abstract
The AIDS epidemic in the Developing World represents a major global crisis. It is imperative that we develop an effective vaccine. Vaccines are economically the most efficient means of controlling viral infections. However, the development of a vaccine against HIV-1 has been a formidable task, and in developing countries chronic parasitic infection adds another level of complexity to AIDS vaccine development. Helminthic and protozoan infections, common in developing countries, can result in a constant state of immune activation that is characterized by a dominant Th2 type of cytokine profile, high IgE levels, and eosinophilia. Such an immune profile may have an adverse impact on the efficacy of vaccines, in particular, an HIV-1 vaccine. Indeed, the CD8 cellular immune response and the corresponding Th1 type cytokines that enhance the CD8 cellular immune response are important for clearing many viral infections. It is believed that an antigen specific CD8 cellular immune response will be an important component of an HIV-1 vaccine.Keywords
This publication has 61 references indexed in Scilit:
- Antibody neutralization and escape by HIV-1Nature, 2003
- A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteersVaccine, 2001
- Safety of 2 Recombinant Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Vaccines in Neonates Born to HIV-1-Infected WomenClinical Infectious Diseases, 2001
- Epidemiology of infections with intestinal parasites and human immunodeficiency virus (HIV) among sugar-estate residents in EthiopiaPathogens and Global Health, 2000
- A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative ThaisVaccine, 2000
- Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteersAIDS, 1998
- Vertical Transmission of Human Immunodeficiency Virus Type 1: Seroreactivity by Maternal Antibodies to the Carboxy Region of the gp41 Envelope GlycoproteinThe Journal of Infectious Diseases, 1997
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.Journal of Clinical Investigation, 1992
- Importance of the nef gene for maintenance of high virus loads and for development of AIDSCell, 1991